openPR Logo
Press release

Mobile Heart Monitoring Market Analysis Report and Industry Forecast to 2024

08-23-2017 03:24 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Mobile Heart Monitoring Market Analysis Report and Industry

Nowadays, the Internet of Things (IoT) is widely recognized by analysts and researchers as the most sophisticated technology, which has potential to not only affect the safety, health, and productivity of many people but also has a big economic impact. It mainly consists of physical objects that are embedded with sensors, computing devices, actuators, and data communication capabilities. These are linked to networks for data transportation. Currently, portable systems for disease diagnosis and monitoring of human functional health are becoming more common. Cardiovascular diseases such as heart disease and stroke remain the leading causes of death around the world. According to a survey conducted by the WHO, about 17.3 million people died of heart disease, which represented 30% of the global deaths in 2008. There has been a significant growth and remarkable progression in the field of the mobile health care market over the years.

Read the Comprehensive Overview of Mobile Heart Monitoring Market: http://www.transparencymarketresearch.com/mobile-heart-monitoring-market.html

Investors have started investing in projects ranging from mobile apps to different sensors. The manufacturers are incorporating advanced sensors with reduced size and low cost, expanding the range of wearable heart monitoring devices. The global mobile heart monitoring market is growing due to technological developments in the mobile health care products and rise in lifestyle diseases and awareness. Furthermore, increase in focus on fitness and healthy lifestyle orientation are anticipated to influence the demand for mobile heart monitoring devices in the near future. Growing trends toward home health care are creating more opportunities for the global heart monitoring market. However, high cost associated with the devices and security issues are projected to hamper the growth of the mobile heart monitoring market.

The global mobile heart monitoring market is segmented on the basis of product, application, end-user, and geography. Based on the product, the global market is categorized into activity monitors, heart rate monitors, EEG/ECG monitors, cardiac event, pulse oximeters, blood pressure monitors, mobile apps, and others. The activity monitors segment is expected to account for a high share of the mobile heart monitoring market. The large market share of the segment are attributed to factors such as increase in unhealthy and sedentary lifestyles, growth in awareness about health and fitness, and rise in health concerns.

On the basis of application, the global market is divided into arrhythmia, high blood pressure, coronary artery disease, fitness, sports, and others. According to the American Heart Association (AHA), arrhythmia afflicts more than 4 million patients and results in approximately half a million deaths in the U.S. Increase in prevalence of arrhythmia globally along with rise in geriatric population are expected to increase the market share of the segment during the forecast period.

On the basis of end-user, the global market is segmented into hospitals, clinics, home care settings, and others (industrial, institutions, academics, and nursing facilities). The hospitals segment is estimated to account for a large share of the market during the forecast period owing to increase in number of chronic cardiac diseases, technological innovation, favorable insurance and reimbursement policies, and rise in per capita health care expenditure.

Based on geography, the global market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global mobile heart monitoring market due to factors such as increase in geriatric population, rapid innovation in technology, and high R&D expenditure. Asia Pacific is poised to be a fast growing region of the market due to increase in aging population, technological advancement, changes in lifestyle, rise in awareness on wellness and fitness, and increase in prevalence of diseases.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20939

The key players operating in this market are Fitbit, Inc., Medtronic, NeuroMetrix, Inc., Samsung Electronics Co. Ltd., LifeWatch AG, Qardio, Inc., Omron Healthcare, Inc., Philips Healthcare, and Apple Inc.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mobile Heart Monitoring Market Analysis Report and Industry Forecast to 2024 here

News-ID: 682275 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an